MedX Health Corp. announced the signing of a commercial distribution agreement with Makromed/Arhan Global A.S following the conclusion of its successful paid pilot project. In conjunction with signing the agreement, Makromed has committed to an initial 60-unit order for 2022, with an immediate order of 40 units and an option for 20 more units to be confirmed by October 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | -11.11% | -5.88% | +33.33% |
05-31 | MedX Health Corp. Brief: Announced Proposed Extension of Non-brokered Private Placement Offering | MT |
05-30 | MedX Health Corp Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+33.33% | 15.26M | |
+9.48% | 222B | |
+13.72% | 195B | |
+23.79% | 148B | |
+33.39% | 113B | |
+4.75% | 66.45B | |
+15.59% | 53.11B | |
+3.16% | 50.03B | |
-4.35% | 38.8B | |
-1.27% | 34.85B |
- Stock Market
- Equities
- MDX Stock
- News MedX Health Corp
- Medx Health Corp. Signs Commercial Distribution Agreement with Makromed/Arhan Global A.S to Launch Medx's Teledermatology Screening Platform in Turkey